引用本文
  • 寇玥婷,成颖莹,王娟,等.5羟色胺4受体激动剂对糖尿病小鼠结肠黏膜巨噬细胞极化的影响[J].同济大学学报(医学版),2021,42(4):453-458,466.    [点击复制]
  • KOU Yue-ting,CHENG Ying-ying,WANG Juan,et al.Effects of 5-HT4R agonist on macrophage polarization in colonic mucosa of diabetic mice[J].同济大学学报(医学版),2021,42(4):453-458,466.   [点击复制]
【打印本页】 【在线阅读全文】【下载PDF全文】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 65次   下载 50 本文二维码信息
码上扫一扫!
5羟色胺4受体激动剂对糖尿病小鼠结肠黏膜巨噬细胞极化的影响
寇玥婷,成颖莹,王娟,戎伟芳,张国花
0
(上海交通大学医学院解剖学与生理学系,上海200025)
摘要:
目的研究5-羟色胺4受体(5-hydroxytryptamine 4 receptor, 5-HT4R)激动剂对糖尿病结肠黏膜巨噬细胞极化的影响。方法使用链脲佐菌素(streptozotocin, STZ)建立小鼠1型糖尿病模型,使用5-HT4R激动剂RS67333进行治疗干预,实验动物随机分为3组,即非糖尿病组、糖尿病对照组和糖尿病给药组。通过免疫荧光方法验证巨噬细胞标记物F4/80和iba1在CX3CR1-GFP+细胞中的表达;通过激光共聚焦显微镜观察CX3CR1-GFP+细胞形态和数目分析结肠黏膜巨噬细胞的活化数量;通过RNAscope技术检测精氨酸酶1(arginase 1, Arg1)和一氧化氮合酶(inducible nitric oxide synthase, iNOS)的表达和分布变化。结果免疫荧光结果显示F4/80和iba1免疫阳性的细胞与CX3CR1-GFP+的细胞基本共定位。与非糖尿病小鼠相比,STZ诱导的1型糖尿病模型小鼠结肠黏膜层活化的巨噬细胞数目增多(P<0.001),且M1型巨噬细胞产物iNOS在黏膜层腔侧表达增加(P<0.001),而M2型巨噬细胞产物Arg1在黏膜固有层表达下降(P<0.001);与糖尿病对照组相比,给予5-HT4R激动剂可以抑制活化的巨噬细胞数目(P<0.001),结肠黏膜iNOS的表达上调(P<0.01)和Arg1的表达下调(P<0.05)。 结论5-HT4R激动剂可以抑制糖尿病小鼠结肠黏膜巨噬细胞向M1型极化。
关键词:  糖尿病  巨噬细胞极化  5-羟色胺4受体
DOI:10.12289/j.issn.1008-0392.21112
投稿时间:2021-03-24
基金项目:国家自然基金面上项目(81770533)
Effects of 5-HT4R agonist on macrophage polarization in colonic mucosa of diabetic mice
KOU Yue-ting,CHENG Ying-ying,WANG Juan,RONG Wei-fang,ZHANG Guo-hua
(Dept. of Anatomy and Physiology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China)
Abstract:
ObjectiveTo investigate the effects of 5-HT4R agonist on the macrophage polarization in the colonic mucosa of diabetic mice. MethodsType 1 diabetes was induced by intraperitoneal injection of streptozotocin(STZ) in CX3CR1-GFP+ C57BL/6 mice. 5-HT4R agonist RS67333 was used for therapeutic intervention. The mice were randomly divided into control group, diabetic group(group D) and RS67333 intervention group(D-RS group). The expression of macrophage biomarkers F4/80 and ionized calcium binding adaptor molecule 1(iba1) in CX3CR1-GFP+ cells was detected by immuno-fluorescence. The activation of macrophages was assessed by observing the change in morphology and number of CX3CR1-GFP+ cells. The expression and distribution of arginase(Arg1) and inducible nitric oxide synthase(iNOS) in colon was detected by RNAscope. ResultsImmunofluorescent assay revealed that F4/80- or iba1- immunoreactive cells and CX3CR1-GFP+ cells were co-localized in cells. Compared with normal control group, the activated macrophages in diabetic group were significantly increased(P<0.001). The expression of iNOS, production of M1 macrophages was increased in the mucosa close to lumen(P<0.001), while the expression of Arg1, production of M2 macrophages was decreased in the laminae propria in diabetic mice(P<0.001). 5-HT4R agonist inhibited diabetes-induced increase of activated macrophages(P<0.001), upregulation of iNOS(P<0.01) and downregulation of Arg1(P<0.05) in the mucosa of colon. Conclusion5-HT4R agonist can inhibit the shift in macrophage polarization from M2 to M1 in diabetic mice.
Key words:  diabetes  macrophage polarization  5-hydroxytryptamine 4 receptor

您是第3076294位访问者
版权所有《同济大学学报(医学版)》编辑部
主管单位:教育部 主办单位:同济大学
地  址: 上海四平路1239号 邮编:200092 电话:021-65980705 E-mail: yxxb@tongji.edu.cn
本系统由北京勤云科技发展有限公司设计